Description

Triamcort 0.2% – Veterinary Corticosteroid Injection

What Is Triamcort 0.2%

• Active Ingredient: Triamcinolone acetonide (0.2%).
• Drug Class: Corticosteroid (glucocorticoid).
• Formulation: Injectable suspension, typically in 10–30 ml vials.
• Purpose: Provides strong anti‑inflammatory and immunosuppressive effects.

Triamcort 0.2% Injection is a white suspension, which settles on standing but readily disperses on shaking. Each ml contains 2mg triamcinolone acetonide as its active substance.Triamcort 0.2% Injection is indicated for the treatment of inflammation and related disorders in dogs and cats. It is also indicated for use in dogs and cats for the management and treatment of acute arthritis, allergic and dermatologic disorders.

Dosage
Dogs and Cats: The dose is a single injection of 0.06ml to 0.11ml of Triamcort 0.2% Injection per kg of body weight in inflammatory or allergic disorders and 0.11ml of Triamcort 0.2% Injection per kg of body weight in dermatologic disorders.

Remission of symptoms, if not permanent, usually lasts 7 to 15 days. After this time, if symptoms recur, the dose may be repeated or oral corticosteroid therapy may be instituted.Horses: Adult animals: 30 ml/day 1st day, 20 ml/day 2nd day, and subsequently 10 ml/day, during 4-6 days.
Foals: 10 ml/day 1st day and 5 ml subsequent 4-6 days.
Pets: 1 ml/15 kg b.w. per day, during 5 days

WITHDRAWAL PERIOD: No withdrawal period. Do not administrate to horses if their meat will be used for human consumption.

reatment of primary locomotor system diseases. Coadjutant treatment to the antibiotic therapy in infectious arthritis. Treatment of inflammatory processes in osteopathies, adenopathies, neuropathies, mastitis. To control congestive and painful symptoms associated to these POSOLOGY:
WITHDRAWAL PERIOD: No withdrawal period. Do not administrate to horses if their meat will be used for human consumption.

reatment of primary locomotor system diseases. Coadjutant treatment to the antibiotic therapy in infectious arthritis. Treatment of inflammatory processes in osteopathies, adenopathies, neuropathies, mastitis. To control congestive and painful symptoms associated to these

Analgesic, anti-inflammatory and anti-pyretic effect indicated in the treatment of locomotor system diseases.

COMPOSITION:

Phenylbutazone 200 mg
Dexamethasone 0.25 mg
Excipient q.s. 1 ml

INDICATIONS:

Treatment of primary locomotor system diseases. Coadjutant treatment to the antibiotic therapy in infectious arthritis. Treatment of inflammatory processes in osteopathies, adenopathies, neuropathies, mastitis. To control congestive and painful symptoms associated to these processes